Success Stories: A Research Associate From India in the Field of Immunology Not Only Achieved NIW Approval But Also Obtained EB-1A Petition Approval 2 Months Apart With Our Zealous Efforts
Client’s Testimonial:
“This is wonderful! It was not possible without your help and expertise, I really appreciate your support and timely response in the entire process. Thanks for working with me, it was my pleasure.”
On July 21st, 2021 and September 22nd, 2021, we received another EB2-NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Research Associate in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Research Associate
Country of Origin: India
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: July 21st, 2021 (NIW) and September 22nd, 2021 (EB-1A)
Processing Time: 10 months, 13 days (NIW) and 8 days (EB-1A) (Premium Processing Requested)
Case Summary:
“As demonstrated by his substantial influence on new immunology research and his work’s acceptance to eminent publications, [client] has already secured a position at the forefront of the field of immunology. Additionally, his active participation in the field also enables necessary domestic progress related to the treatment of cancer. For these reasons, I strongly recommend [client] be allowed to continue his work in the United States.”
“[Client’s] vast experiences have provided him with a comprehensive skill set and level of ingenuity that few researchers possess, and his studies also facilitate the development of enhanced treatments for cancer and autoimmune diseases. As such, the United States is well-served by taking advantage of the excellent training he has received and facilitating his continued employment in the nation.”
The aforementioned two statements have been extracted from 2 of the 4 recommendation letters submitted by our client, acquired from the well-known researchers in the field of immunology.
Our client, a research associate holding a Ph.D. in biotechnology (immunology), approached North America Immigration Law Group as he was certain that our law firm would support him to achieve his NIW (National Interest Waiver) petition approval. As per our services, we advised him to submit more evidence along with his letters of support to further this case. Accordingly, after reviewing his credentials, undeniably, we were dazzled and agreed to take his case forward to USCIS for further adjudication.
After we filed our client’s I-140 NIW petition, he retained our services to get one more petition filed under the I-140 EB-1A (Alien of Extraordinary Ability) visa category. We affirmed articulating another petition on his behalf without any hesitation and laid out unique structures in the respective cases and mentioned the following details:
One of the foremost aspects we noted was his research into cancer immunology, focusing on novel immunotherapeutic treatments for pancreatic cancer, in particular by using flow cytometry and animal models to conduct preclinical tests of these treatments. His intention to continue his innovative research in his area of extraordinary ability and continue to advance the field through fundamental and applied research is of immeasurable importance because it advances the development of novel therapeutic approaches for the treatment of cancer and auto-immune diseases, which positively impact global efforts to alleviate the severe burdens of these diseases.
Moreover, we discussed the 261 citations accumulated from 15 peer-reviewed papers and 1 book chapter, he published in international journals. There, his recurrent inclusion in such titles is a testament to his research’s saliency and high value. Additionally, our client has completed and published the results of his research in the field, but his discoveries have also gone on to influence his peers. That is, his publications have been cited by researchers in at least 31 countries, and he has conducted at least 130 reviews to date. Furthermore, he even sits on the editorial board of the 15 journals thereby demonstrating that these publications are widely recognized and relied upon in his field of expertise.
Finally, we showcased that his research was financially supported by grants from the National Institutes of Health (NIH). As this funding is reserved solely for research that advances national goals related to the health and well-being of Americans, this funding confirms the national value of the client’s research for the United States and improved national public health. His research even received funding from the Indian Department of Biotechnology. Thus, his research has not only attracted the attention and acclaim of other researchers in immunology and oncology but from prominent government and foreign research institutions as well.
The direct benefits of the client’s research are therefore apparent, considering the prevalence of cancer in the United States and his research is likewise essential to improving the ability to treat this incurable disease and improving the prognosis for cancer patients.
Overall, we are super excited that our client allowed us to manage both his I-140 petitions and be a part of this success story since he obtained his I-140 NIW and EB-1A approvals 2 months apart. And thanks to the Premium Processing service upgrade for his EB-1A case, which was adjudicated in just 8 days. We are glad that once again our team’s efforts and diligence in both our client’s cases paid off well and would like to congratulate him as he advances in his chosen field of expertise.